Clinical Trials Browser

Phase 1 × OTHER × lorcaserin × Clear all

NCT04205071 2021-01-19

Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer

Phase 1 Withdrawn

Anatomic Stage I Breast Cancer AJCC v8